The RECLAIM study is a placebo-controlled trial designed to evaluate the efficacy and safety of Pemvidutide, a novel GLP-1/glucagon receptor dual agonist, in adults with AUD who are also overweight or obese.
Need additional information?
Black or African American
Latino
White
API
American Indian or Alaska Native
Other
Male
Female
Transgender
Gender Non-binary
Facebook
Instagram/Twitter
Flyer
Dating App (Grindr, Growlr, Adam4Adam, etc.)
Online
Word-of-mouth